R78C
- Generic Name
- R78C
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)
Phase 1
Not yet recruiting
- Conditions
- Malaria,Falciparum
- Interventions
- First Posted Date
- 2025-05-06
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 56
- Registration Number
- NCT06958198
- Locations
- 🇧🇫
Institut de Recherche en Sciences de la Santé, Sigle,, Boulkiemdé Province, Burkina Faso
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath